III期ReSPECT研究已完成入组,该研究旨在预防接受异基因血液和骨髓移植的成人患者发生真菌感染 ReSPECT研究的主要结果预计将于2026年中期公布 英国剑桥--(BUSINESS WIRE)--(美国商业资讯)-- Mundipharma今日宣布,正在进行的全球III期ReSPECT试验已完成患者招募,该试验 ...
STARLIMS, a global leader in Laboratory Information Management Systems (LIMS) and informatics solutions, today announced ...
Takeda to Receive Rights to Two Next-Generation Late-Stage Investigational Medicines, Worldwide Outside of Greater China, and an Exclusive Option to License Global Rights to an Early-Stage ...
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free ...
Chemify raises > US $50 million in Series B funding to globalise its AI-driven digital chemistry and molecule-manufacturing ...
Named after Dr. James Robert Cade, the lead inventor of Gatorade, the Cade Prize for Inventivity celebrates early-stage ...
This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and ...
New tool helps sponsors measure, manage and minimize the environmental impact of researchWILMINGTON, N.C.--(BUSINESS ...
Black Book survey reveals just 1 in 4 hospitals can fully exchange patient data across national boundaries in Q4 2025 VIENNA, ...
Challenges and New Momentumchina’s pharmaceutical innovation goes global challenges and new momentumIn the first five months ...
IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic ...
The Eurofins (Paris:ERF) network of companies delivered steady improvement in organic revenue growth during the first nine ...